Speakers - Sachs Associates

CONTACT
Roberto De Ponti
Head of Corporate Business
Development
ADDRESS
Helsinn Healthcare SA
Via Pian Scairolo,
6912 Lugano-Pazzallo
Switzerland
TELEPHONE
+41 91 985 21 21
Roberto De Ponti
Direct line: +41 91 985 21 21
FAX
+41 91 993 21 22
EMAIL
info-HHC@helsinn.com
rp@helsinn.com
YEAR FOUNDED
1976
Helsinn
www.helsinn.com
FINANCIAL SUMMARY
Helsinn Group’s 2011 Total Net Turnover: CHF 300.2M – EUR 243.9M
Helsinn Group’s 2011 Total Assets: CHF 436.1M – EUR 359.2M
Helsinn Group’s R&D Investments in last 5 years: CHF 298.5M
Helsinn Group’s Staff: Total = 455
Switzerland = 277
Ireland = 141
USA = 37
COMPANY PROFILE
Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating
subsidiaries in Ireland and the United States. Helsinn’s business model is focused on the licensing of
pharmaceuticals, medical devices and nutritional supplement products in therapeutic niche areas. Helsinn Group
in-licenses early-to-late stage new chemical entities, completes their development through the performance
of pre-clinical /clinical studies and Chemistry, Manufacturing, and Control (CMC) development, and files and
attains their market approvals worldwide. Helsinn’s products are out-licensed to its network of local marketing
and commercial partners, selected for their deep in-market knowledge and know-how whom Helsinn assists
and supports by providing a full range of product and scientific management services, including commercial,
regulatory financial, legal, and medical marketing advice. The active pharmaceutical ingredients and the finished
products are manufactured according to the highest quality, safety, and environmental standards at Helsinn’s
GMP facilities in Switzerland and Ireland and supplied worldwide to its customers.
Further information on Helsinn Group is available at www.helsinn.com.
MANAGEMENT
Dr Gabriele Braglia, Founder & Chairman
Dr Riccardo Braglia, Helsinn Group CEO, Board Member & US Chairman
Dr Luigi Caletti, Group Chief Financial Officer, Board Member & US Board Member
Dr Giorgio Calderari, Group General Manager & Chief Operating Officer & US Board Member
Dr Roberto De Ponti, Senior Director, Head of Corporate Business Development
Dr Andrea Meoli, Chief Commercial Officer
Dr Sergio Cantoreggi, Chief Scientific Officer
Dr Matteo Missaglia, Senior Director, General Counsel, Corporate Legal Affairs
Dr Daniele Bonadeo, Senior Director, Head of Corporate Technical
Dr Paolo Guainazzi, Local General Manager, Chemical Business, Helsinn Advanced Synthesis
Dr William Mann, Local President & CEO & Board Member US Pharma Business, Helsinn Therapeutics (U.S.), Inc.
Dr Padraig Somers, Local General Manager, Pharma Business, Helsinn Birex Pharmaceuticals, Ireland
t back :: next u
WELCOME PHARMA LICENSING GROUPS
SPEAKERS
PRESENTING COMPANIES SUPPORTING ORGANISATIONS
ORGANISERS